Holen Sie sich die Stockscreener-App
3.02
3.82%
-0.12
Vorhandelsmarkt:
3.01
-0.01
-0.33%
Schlusskurs vom Vortag:
$3.14
Offen:
$3.195
24-Stunden-Volumen:
865.74K
Relative Volume:
0.74
Marktkapitalisierung:
$305.66M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-2.4553
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
-9.04%
1M Leistung:
+6.34%
6M Leistung:
+233.96%
1J Leistung:
-33.63%
1-Tages-Spanne:
$3.00
$3.24
1-Wochen-Bereich:
$3.00
$3.2945
52-Wochen-Spanne:
$0.87
$6.14
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
3.02 | 317.81M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Will Alector Inc. stock attract ESG investorsJuly 2025 Retail & Weekly Momentum Picks - newser.com
Will Alector Inc. stock maintain dividend yieldTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Combining machine learning predictions for Alector Inc.Portfolio Growth Summary & Risk Managed Investment Signals - newser.com
Analyzing drawdowns of Alector Inc. with statistical toolsShort Setup & Weekly High Conviction Trade Ideas - newser.com
What MACD and RSI say about Alector Inc.Market Rally & Expert-Curated Trade Recommendations - newser.com
Is Alector Inc. stock supported by strong cash flowsWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Custom watchlist performance reports with Alector Inc.Trade Analysis Report & Proven Capital Preservation Methods - newser.com
What recovery options are there for Alector Inc.July 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
Is now a turning point for Alector Inc.Insider Buying & Step-by-Step Swing Trade Plans - newser.com
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - Benzinga
Key metrics from Alector Inc.’s quarterly data2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Chart overlay techniques for tracking Alector Inc.2025 Fundamental Recap & Community Driven Trade Alerts - newser.com
Can Alector Inc. stock maintain operating marginsJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
Is Alector Inc. stock positioned for long term growth2025 Major Catalysts & High Conviction Trade Alerts - newser.com
Reversal indicators forming on Alector Inc. stockTake Profit & Risk Controlled Stock Pick Alerts - newser.com
Ranking Alector Inc. among high performing stocks via toolsQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Alector's (ALEC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
3 Promising Penny Stocks With Market Caps Under $400M - simplywall.st
Alector Stock: Unlocking Middle Aged Dementia (NASDAQ:ALEC) - Seeking Alpha
Alector, Inc. (NASDAQ:ALEC) is a favorite amongst institutional investors who own 70% - Yahoo
Is Alector Inc. stock bottoming outWeekly Trend Recap & Low Risk Entry Point Guides - newser.com
Why Alector Inc. (0Z2) stock remains stablePortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Cantor Fitzgerald Forecasts Weaker Earnings for Alector - Defense World
Cantor Fitzgerald Predicts Lower Earnings for Alector - MarketBeat
Why analysts remain bullish on Alector Inc. stock2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Will INFRONT-3 Data Bring Alector To The Forefront Of Frontotemporal Dementia Treatment? - RTTNews
Alector Inc Stock Analysis and ForecastReal Estate Investment Trusts & Plan Every Trade With Controlled Risk - earlytimes.in
What drives Alector Inc stock priceEvening Star Patterns & Exceptional Growth Investment - earlytimes.in
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alector Inc-Aktie (ALEC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Berkley Neil Lindsay | Principal Financial Officer |
Sep 02 '25 |
Sale |
2.50 |
15,842 |
39,554 |
346,570 |
| Kenkare-Mitra Sara | President and Head of R&D |
Sep 02 '25 |
Sale |
2.50 |
23,638 |
59,019 |
543,339 |
| Rosenthal Arnon | Chief Executive Officer |
Sep 02 '25 |
Sale |
2.50 |
51,562 |
128,740 |
2,350,220 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):